Management of the pregnant mother with malignant conditions

Current Opinion in Obstetrics & Gynecology
V Sivanesaratnam

Abstract

A malignancy discovered in pregnancy is often difficult to manage; the optimal maternal therapy has to be balanced with the fetal well-being. Generally, the cancer is managed as though the patient is not pregnant. For the various site-specific cancers, surgery is the main modality of treatment; this should be individualized. Chemotherapeutic agents are highly teratogenic in the first trimester, with some adverse effects when used after 12 weeks' gestation. The overall survival rate for pregnancy-associated breast cancer is poor; the reasons for this are discussed. For cervical cancer, delivery by caesarean section appears to be the method of choice, with significantly better survival rates compared with those who deliver vaginally. Other gynaecological and non-gynaecological malignancies are discussed.

References

Oct 1, 1990·The Surgical Clinics of North America·H C Hoover
Sep 1, 1989·Clinical Oncology : a Journal of the Royal College of Radiologists·R M Clark, T Chua
Jan 1, 1989·Seminars in Surgical Oncology
Jul 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B Bostrom, B L Mirkin
Oct 5, 1987·The Medical Journal of Australia·P R Kitchen, R McLennan
Oct 1, 1987·American Journal of Obstetrics and Gynecology·J L BenedetK G Nickerson
Aug 1, 1986·British Journal of Obstetrics and Gynaecology·J M Monaghan, G Lindeque
Mar 1, 1968·The Journal of Obstetrics and Gynaecology of the British Commonwealth·H O Nicholson
Mar 1, 1983·Current Problems in Cancer·M K WallackS Wilson-Krechel
Jul 1, 1994·Cancer·J A Petrek
Apr 24, 1993·Lancet·A de la RochefordiereA Fourquet
Jan 1, 1993·Gynecologic Oncology·V SivanesaratnamC Loo
Apr 1, 1996·The Surgical Clinics of North America·L A DiFronzo, T X O'Connell
Jun 15, 1996·American Journal of Epidemiology·C P McPhersonA R Folsom
Jan 1, 1997·Gynecologic Oncology·W R RobinsonA G O'Quinn
Dec 31, 1997·Gynecologic Oncology·A CoppolaR E Buller
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L BerryG N Hortobagyi
Apr 3, 1999·British Journal of Cancer·L S DobsonB W Hancock
Jul 20, 1999·American Journal of Obstetrics and Gynecology·M P WhitecarM K Higby
Oct 20, 1999·Gynecologic Oncology·A AyhanU Oz

❮ Previous
Next ❯

Citations

Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F Ghaemmaghami, M Hasanzadeh
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A V Dy Echo, A S Soriano-Estrella

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Obstetricia Et Gynecologica Scandinavica
C BaykalI Dölen
European Journal of Obstetrics, Gynecology, and Reproductive Biology
M MikamiC Tei
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
O OlayemiI J Udoh
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists
© 2021 Meta ULC. All rights reserved